Inotuzumab ozogamicin(635715-01-4)
- Name: Inotuzumab ozogamicin
- Synonyms:Inotuzumab ozogamicin
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:635715-01-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.635715-01-4 Inotuzumab ozogamicin
Assay:99% Package:according to customer requirements Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.635715-01-4 Inotuzumab ozogamicin
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Inotuzumab ozogamicin
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.635715-01-4 Inotuzumab ozogamicin
Assay:97% Appearance:clear oily liquid Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States] CAS No.635715-01-4 Inotuzumab ozogamicin CAS No.635715-01-4
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)]
Other Product
- 1234616-01-3/Methyl 5-aMino-7-azaindole-3-carboxylate
- 940933-27-7/Ethyl 2-(3-(trifluoromethyl)pyridin-2-yl)acetate
- 887268-01-1/5,6-Bis(difluoromethoxy)-1,3-benzothiazol-2-amine, 5,6-Bis(difluoromethoxy)benzo[d]thiazol-2-amine
- 145369-92-2/7-bromo-2-hydrazinylQuinoxaline
- 55256-12-7/2,3-Dihydro-3-[2-methyl-3-(4-nitrophenyl)-1-propenylidene]furan
- 1218765-26-4/FORMIC ACID-12C SODIUM SALT
- 602262-06-6/3-BUTOXYPROP-1-YLISOCYANIDE
- 641571-44-0/2-AMino-6-chloro-9-[(2,3,5-tri-O-benzoyl- 2-C-Methyl-β-D-ribofuranosyl)]-9H-purine
- 94206-84-5/2-(ChloroMethyl)-6-Methyl-4-phenyl-quinazoline 3-Oxide
- 1171920-21-0/6-((tert-Butyldimethylsilyloxy)methyl)-furo[3,2-b]pyridine
- 26469-05-6/13-(4-Acetyloxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyl-4-acetyloxytridecane
- 1312464-83-7/4-(1-(6-bromopyridin-2-yl)azepan-4-ylamino)butan-1-ol
- 161327-47-5/4,7-DIMETHOXYQUINOLINE
- 667413-64-1/ART-CHEM-BB B018165
- 1221567-17-4/4-Chloro-5-methyl-pyrimidine hydrochloride
- 850896-71-8/Etoricoxib-d3
- 99057-99-5/2-(6-BROMO-QUINAZOLIN-4-YLAMINO)-ETHANOL
- 1353965-22-6/2-[(1-Thiazol-2-yl-ethylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester
- 181585-07-9/3-broMo-5-(2-Methoxyethoxy)pyridine
- 635715-01-4/Inotuzumab ozogamicin
- 27542-41-2/4-CHLORO-D-TRYPTOPHAN
- 898782-14-4/4-BROMO-2-FLUORO-2'-THIOMORPHOLINOMETHYL BENZOPHENONE
- 1427753-68-1/1-(bromomethyl)-2,5-dichloro-4-methoxybenzene
- 114010-54-7/2-[2-(1H-Imidazol-1-yl)ethyl]-2,5,7,8-tetramethylchroman-6-ol
- 194783-82-9/TIMTEC-BB SBB000959
- 400827-64-7/7 β - aMino - 3 - [4 - pyridyl - 2 - thiazole sulfur radical ] - 3 - cepheM - 4 - carboxylic acid ·2HCl
- 864350-82-3/2-(1,4-diazepan-1-yl)-N,N-dimethylethanamine
- 42119-89-1/Spiro[cyclohexane-1,4-[2,3]diazabicyclo[3.1.0]hexane] (9CI)
- 1421026-41-6/(S)-1-[3-(Cyclopropyl-Methyl-aMino)-propyl]-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile
- 363162-67-8/N-(2-FLUOROPHENYL)-N-(METHYLSULFONYL) GLYCINE